Let’s talk the latest in AF innovation at HRS 2016!

Share

According to the Heart Rhythm Society, “More than 900 of the world’s most noted experts in cardiac rhythm management will serve as faculty for more than 250 educational sessions covering topic areas including pacing, defibrillation, clinical arrhythmia management, ablation, pharmacology, genetics, basic science, health policy, and many other topics.” 

Having attended the annual Heart Rhythm Society Scientific Sessions for the past five years, we can attest to its industry leading role in the gathering of electrophysiology experts year after year. We can’t wait for HRS 2016!

When it comes to atrial fibrillation, ablation catheters, mapping catheters, energy-based or navigational devices or  – any medical device or technology that addresses abnormal heart rhythm – we’re in!

T3 Labs has completed more than 80 studies including 15 GLP studies from which 10 products, such as generators, ablation catheters, diagnostic EP catheters, have achieved regulatory approval and are now on the market improving the lives of cardiac patients worldwide.

We know GLP.

Our AAALAC accredited preclinical CRO has archived more than 50 GLP studies across all program areas from which more than 30 medical devices have achieved regulatory approval. GLP in 8 days? Yes, it’s possible.

We have the equipment and capabilities you need.

Proper navigation and placement of devices is critical. Our GE Vivid I Echo system enables perfect trans-septal placement via intra-cardiac echocardiography (ICE), our fixed Philips Cathlab with a full CardioLab suite allows exceptional fluoroscopy, hemodynamic monitoring, and EP recording. Access to CT and MRI allows the monitoring of any post-ablation material. Additionally, we can support evaluations in thigh muscle and offer expertise in myocardial infarction models that provide with a disease ready state for the evaluation of your device. . T3 Labs has the medical imaging equipment and expertise needed to accelerate and maximize your investment in preclinical testing.

You need a trusted GLP partner.

For these reasons and more, like our staff of surgical specialists and DVMs, CardioMEMS (now part of St. Jude Medical) relied on T3 Labs to help bring the first of its kind implantable wireless device implanted in the pulmonary artery to monitor pulmonary artery pressures to market.

“At the preclinical stage of medical device product development, there is an important opportunity to identify and implement significant improvements before first clinical use. T3 Labs provides extensive expertise and capabilities in the critical preclinical stage of medical device product development.” – Jason White, Senior Director of Product Development, St. Jude Medical

 

HRS 2016Are you evaluating your EP device’s readiness for preclinical testing, or need valuable feedback from clinicians? Or do you just want to talk about the latest in AF innovation? We want to connect with you at HRS 2016.

Contact Chris Rolfes
christopher.rolfes@emoryhealthcare.org
404-251-0622